In vivo |
Myeloid PTEN-deficient mice/bleomycin |
Loss of PTEN expression |
Sustained activation of PI3K pathway |
Increased TGF-β1 activation, collagen deposition; reduced number of macrophages and T-cells |
[93] |
In vivo/in vitro |
Human IPF lung tissue; IPF lung tissue; C57BL/6 and A549 cells/bleomycin |
Loss of PTEN |
P21WAF1, P16ink4, and SA-β-gal overexpression; NF-κB and Akt activation |
Alveolar epithelial cell senescence promotes lung fibrosis |
[94, 95] |
In vivo/in vitro |
Human lung tissue; C57BL/6 embryonic mouse fibroblasts and 3T3 murine fibroblasts/TGF-β1; C57BL/6 mice/bleomycin |
Diminished PTEN expression and phosphatase activity |
Inhibition of PTEN activity in IPF-derived fibroblasts |
α-SMA expression, cell proliferation, collagen production, and myofibroblast differentiation |
[97] |
In vivo/in vitro |
Primary fibroblast cell lines from IPF and healthy lung/type I collagen–rich matrix; PTEN haploinsufficient and wild-type mice/bleomycin |
High phosphatase activity in normal lung fibroblasts, but low activity in IPF-derived fibroblasts |
Aberrant activation of the PI3K–Akt–S6K1 signaling pathway in IPF-derived fibroblasts |
Enhanced the proliferation of primary lung fibroblasts |
[99] |
In vitro |
Fibroblasts and myofibroblasts from patients with IPF; MRC-5 cells/H2O2
|
Loss of PTEN expression |
Activated the TGF-β1 pathway and increased hyaluronan synthase 2 expression |
Increased proliferation, apoptosis resistance, and migration/invasion activities |
[100] |
In vivo/in vitro |
Human IPF lung tissue; MRC-5 cells/TGF-β1 |
PTEN ubiquitination and degradation |
Downregulation of ubiquitin-specific peptidase 13 (USP13) |
Enhanced proliferative, migratory, and invasive capacities of lung fibroblasts |
[101] |
In vivo/in vitro |
Human IPF lung tissue; HFL-I cells/TGF-β1 |
Low expression of PTEN |
Enhanced PI3K/Akt and TGF-β/Smad3 signaling |
PTEN inhibited the proliferation and myofibroblast differentiation and promoted the apoptosis of fibroblasts |
[102] |
In vitro |
Human lung fibroblasts CCL-210/mechanical stretch |
Increased PTEN activity |
Decreased Akt phosphorylation |
Promoted fibroblast apoptosis |
[106] |
In vitro |
Primary IPF-derived and normal fibroblasts/polymerized type I collagen |
Low phosphatase activity |
High Akt activity promoted the inactivation of FoxO3a and downregulation of p27 in IPF-derived fibroblasts |
Facilitated fibroblast proliferation |
[107] |
In vitro |
Primary control and IPF-derived lung fibroblasts/polymerized type I collagen |
Low phosphatase activity |
Inactivation of FoxO3a, which downregulated caveolin-1 and Fas expression |
Apoptosis-resistant phenotype of IPF-derived fibroblasts |
[108] |
In vitro |
Primary IPF-derived lung fibroblasts/polymerized type I collagen |
Decreased phosphatase activity |
Enhanced p-mTOR expression along with low expression of LC3-2 and FoxO3a |
Suppressed autophagic activity |
[109, 110] |
In vivo/in vitro |
Primary human alveolar epithelial type II (AEII) cells; small-airway epithelial cells/mechanical stretch |
Downregulation of PTEN |
miR-19a overexpression |
Development of the EMT phenotype and lung fibrosis |
[111] |
In vitro |
Murine embryonic fibroblasts/LPS |
Low PTEN expression |
Upregulation of TLR4 and PI3K/Akt pathway activation |
Increased fibroblast proliferation |
[112] |
In vitro |
Primary IPF-derived lung fibroblasts; normal human fetal lung fibroblasts (IMR-90) |
Low PTEN expression and phosphatase activity |
Loss of α4β1 signaling |
Migratory/invasive phenotype of fibroblasts |
[113] |
In vitro |
IMR-90 cells; murine embryonic fibroblasts/prostaglandin E2 |
Increased PTEN phosphatase activity by decreasing the phosphorylation of PTEN |
E-prostanoid (EP) 2 receptor |
Inhibited fibroblast migration |
[115] |
In vivo/in vitro |
Human embryo lung fibroblasts/silica |
Loss of PTEN expression due to hypermethylation of its promoter |
MAPK and c-Jun methylation |
|
[116] |
In vitro |
Deletion of PTEN or both PTEN and CCN2 in mouse fibroblasts |
Loss of PTEN expression |
Overproduction of collagen type I and connective tissue growth factor (CCN2) |
Collagen deposition |
[117] |
In vitro |
Epithelial H358 cells; normal human adult lung fibroblasts CC2512 and primary mouse lung fibroblasts /unphosphorylated PTEN/TGF-β1 |
Loss of PTEN enzymatic activity via phosphorylation of its C-terminus; retention of enzymatic activity in PTEN4A-treated cells |
Suppression of β-catenin translocation by PTEN4A treatment |
PTEN4A inhibits ECM production |
[118] |